NCT02174029

Brief Summary

When a person is put on a breathing machine the investigators think that the breathing muscles can get weaker. The investigators are not sure how quickly this happens but in some people this leads to problems when they try to breathe on their own without the breathing machine. The diaphragm is at the bottom of a person's chest separating their lungs from what is in their belly and it is a very strong muscle. In fact, it is main muscle that one uses for breathing. An ultrasound machine is a painless way to see what is happening beneath the skin. It is safe and easy to do. Using an ultrasound the investigators are planning to measure how thick the diaphragm is and how much it changes while a person is on a breathing machine in the ICU. Getting a better understanding of this condition could lead to improved treatments that might help support patients who require a ventilator for breathing. The investigators hypothesis is that patients for whom the breathing machine is doing all of the work of breathing, will have their diaphragm thickness gradually decrease and changing to a breathing modem mode where they have to put in more effort the diaphragm thickness will start increasing again.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2014

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2014

Completed
5 days until next milestone

Study Start

First participant enrolled

June 1, 2014

Completed
24 days until next milestone

First Posted

Study publicly available on registry

June 25, 2014

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

March 11, 2015

Status Verified

March 1, 2015

Enrollment Period

2 months

First QC Date

May 27, 2014

Last Update Submit

March 9, 2015

Conditions

Keywords

AtrophyVentilatorInducedDiaphragmDysfunction

Outcome Measures

Primary Outcomes (1)

  • US measurement of diaphragm and quadriceps thickness

    Diaphragm thickness will be measured once per day and continue until extubation, liberation from mechanical ventilation, transfer to another facility, death, or study completion.

    Participants will be ultrasounded daily until they are extubated or the 3 month study period has ended, the expected average duration of mechanical ventilation is 4.4 days at our institution

Secondary Outcomes (15)

  • Quadriceps muscle thickness

    Participants will be ultrasounded daily until they are extubated or the 3 month study period has ended, the expected average duration of mechanical ventilation is 4.4 days at our institution

  • PEEP (Postive end expiratory pressure) applied by the mechanical ventilator at the time of the ultraspound

    Participants will be ultrasounded daily until they are extubated or the 3 month study period has ended, the expected average duration of mechanical ventilation is 4.4 days at our institution

  • re-intubated within 48 hours

    followed for 48 hours post extubation, or 3 month study period has ended

  • mean daily fluid balance

    Will be recorded daily until they are extubated or the 3 month study period has ended, the expected average duration of mechanical ventilation is 4.4 days at our institution

  • mean daily FiO2 (oxygen level administered)

    Will be recorded daily until they are extubated or the 3 month study period has ended, the expected average duration of mechanical ventilation is 4.4 days at our institution

  • +10 more secondary outcomes

Study Arms (3)

Ventilation- mandatory mode only

those patient ventilator days during which they had only received a mandatory mode of ventilation

Procedure: Ventilation- mandatory

Ventilation- voluntary mode only

Those patient days on a mechanical ventilator who have not received prior mandatory ventilation during this episode of mechanical ventilation.

Procedure: Ventilation- voluntary mode only

voluntary with preceding mandatory

Those patient ventilator days where the patient had at least one prior day of mandatory mechanical ventilation during this episode of respiratory support.

Procedure: Voluntary with preceding mandatory

Interventions

Patient days during which only a mandatory ventilation mode was used and prior to this no voluntary mode was used.

Ventilation- mandatory mode only

Patient days on a voluntary mode with no preceding days with a majority of time spend on a mandatory mode

Ventilation- voluntary mode only

Patient days on a voluntary vent mode with at least one day prior during which the majority of the vent mode was mandatory.

voluntary with preceding mandatory

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Mechanically ventilated critical ill patients

You may qualify if:

  • All patients age ≥19 years in the ICU on ventilation

You may not qualify if:

  • History of diaphragmatic or neuromuscular disease
  • On a home ventilator
  • History of diaphragm surgery
  • Absence of adequate initial US images (3 consecutive days with at least 2 operators)
  • BMI greater than 40

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Columbian Hospital

New Westminster, British Columbia, V3L 3W7, Canada

Location

MeSH Terms

Conditions

Muscular AtrophyAstheniaAtrophy

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Steven Reynolds, MD

    Royal Columbian Hospital, Fraser Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head and Research Director, Department of Critical Care, Royal Columbian Hospital

Study Record Dates

First Submitted

May 27, 2014

First Posted

June 25, 2014

Study Start

June 1, 2014

Primary Completion

August 1, 2014

Study Completion

September 1, 2014

Last Updated

March 11, 2015

Record last verified: 2015-03

Locations